mebeverine has been researched along with Exocrine Pancreatic Insufficiency in 1 studies
mebeverine: RN given refers to parent cpd; structure
Exocrine Pancreatic Insufficiency: A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gubergrits, NB | 1 |
| Lukashevich, GM | 1 |
1 review available for mebeverine and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
[Cholestasis and pancreatic insufficiency: how to start treatment?].
Topics: Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Replacement Therapy; Ex | 2014 |